Close Menu

A study that found that people's genes can determine whether they will lose weight on a low-fat or low-carb diet has made a splash. "Knowing your genotype for low-carb or low-fat diets could help you increase your weight-loss success," Stanford University's Christopher Gardner, a co-author of the study, told the Wall Street Journal. Interleukin, the sponsor of the study and the developer of the test, sells it for $149.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.